E
EverZom
Biotech & Life Sciences · Paris, France · Founded 2019
A key asset to the future health of an ageing population MoreLess
Developer of a GMP-compliant extracellular vesicle manufacturing platform based on a unique proprietary technology designed for pharmaceutical researchers. The company's extracellular vesicles have protective and reparative properties representing an important therapeutic tool, thereby enabling healthcare professionals to use them to overcome the failure of an organ, restoring its function and homeostasis. Keywords: Pharmaceuticals and Biotechnology, Bio Medicine Company, Bio Medicine Platform, Bio Production Systems, Biomedical Research, Bioproduction Facility, Nanomedecine Biotech Company, Regenerative Medicine.
Talent graph
EverZom's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where EverZom has talent and traffic
team presence
Market sentiment
What the market is saying about EverZom
An AI-synthesized read of the highest-engagement posts about EverZom on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EverZom on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.








